Multi-epitope antigen, immunogenic composition comprising said antigen, pneumococcal diagnostic kit, and uses of said antigen
WO2024259508A1PCT designated stage expired Publication Date: 2024-12-26INSTITUTO BUTANTAN
-1 Cites -1 Cited by
Patent Information
- Application Number
- PCT/BR2024/050260
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-22
- Filing Date
- 2024-06-18
- Publication Date
- 2024-12-26
Smart Images

Figure BR2024050260_26122024_PF_FP_ABST
Abstract
The present invention relates to a multi-epitope antigen comprising 20 epitope blocks of 20 to 36 amino acids from proteins selected from the group consisting of NanA, PcsB, PhtD, Ply, PncO, StkP, PspA-F1 and PspA-F2. In addition, the present invention relates to an immunogenic composition comprising said antigen and a pharmaceutically acceptable vehicle and / or adjuvant. In addition, a pneumococcal diagnostic kit comprising said antigen or a biologically active fragment thereof bound to a detectable fraction; an antibody generated by said antigen; and instructions for use is also disclosed. In addition, the present invention relates to the use of said antigen to be used in the preparation of a vaccine to prevent diseases caused by pneumococcus bacteria; and for the production of monoclonal and polyclonal antibodies. Lastly, the present invention relates to an in vitro method for diagnosing pneumococcus which comprises applying the said antigen or a biologically active fragment of it bound to a detectable fraction, in contact with samples of body fluids selected from among blood, mucus expelled from the lower airways and urine.
Need to check novelty before this filing date? Find Prior Art
